Institution
Monroe Carell Jr. Children's Hospital at Vanderbilt
Healthcare•
About: Monroe Carell Jr. Children's Hospital at Vanderbilt is a based out in . It is known for research contribution in the topics: Population & Medicine. The organization has 1046 authors who have published 1262 publications receiving 28063 citations. The organization is also known as: Vanderbilt Children's Hospital.
Papers published on a yearly basis
Papers
More filters
••
Monroe Carell Jr. Children's Hospital at Vanderbilt1, University of Alabama at Birmingham2, Columbia University Medical Center3, Cleveland Clinic4, University of Texas Southwestern Medical Center5, University of Florida6, University of Alberta7, University of Mississippi Medical Center8, Boston Children's Hospital9, University of Virginia10, Anschutz Medical Campus11, Children's Hospital of Wisconsin12, Children's Hospital Los Angeles13, Duke University14
TL;DR: In this article, the authors assess the center variation in methods used to diagnose rejection in the first-year post-transplant and determine the impact of this variation on patient outcomes.
Abstract: Background Freedom from rejection in pediatric heart transplant recipients is highly variable across centers. This study aimed to assess the center variation in methods used to diagnose rejection in the first-year post-transplant and determine the impact of this variation on patient outcomes. Methods The PHTS registry was queried for all rejection episodes in the first-year post-transplant (2010-2019). The primary method for rejection diagnosis was determined for each event as surveillance biopsy, echo diagnosis, or clinical. The percentage of first-year rejection events diagnosed by surveillance biopsy was used to approximate the surveillance strategy across centers. Methods of rejection diagnosis were described and patient outcomes were assessed based on surveillance biopsy utilization among centers. Results A total of 3985 patients from 56 centers were included. Of this group, 873 (22%) developed rejection within the first-year post-transplant. Surveillance biopsy was the most common method of rejection diagnosis (71.7%), but practices were highly variable across centers. The majority (73.6%) of first rejection events occurred within 3-months of transplantation. Diagnosis modality in the first-year was not independently associated with freedom from rejection, freedom from rejection with hemodynamic compromise, or overall graft survival . Conclusions Rejection in the first-year after pediatric heart transplant occurs in 22% of patients and most commonly in the first 3 months post-transplant. Significant variation exists across centers in the methods used to diagnose rejection in pediatric heart transplant recipients, however, these variable strategies are not independently associated with freedom from rejection, rejection with hemodynamic compromise, or overall graft survival.
7 citations
••
Monroe Carell Jr. Children's Hospital at Vanderbilt1, Vanderbilt University2, Ohio State University3, Nationwide Children's Hospital4, Columbia University5, George Washington University6, All Children's Hospital7, Hospital for Sick Children8, Boston Children's Hospital9, Baylor College of Medicine10, Children's Hospital of Wisconsin11, University of Texas Health Science Center at San Antonio12, University of Colorado Boulder13, University of Texas MD Anderson Cancer Center14, Children's Hospital Los Angeles15
TL;DR: The Children's Oncology Group (COG) Young Investigator (YI) Committee designed a mentorship program in 2004 whose purpose was to pair YIs with a senior mentor to assist with career development and involvement in COG research activities.
Abstract: Background Mentorship of junior faculty is an integral component of career development. The Children's Oncology Group (COG) Young Investigator (YI) Committee designed a mentorship program in 2004 whose purpose was to pair YIs (faculty ≤10 years of first academic appointment) with a senior mentor to assist with career development and involvement in COG research activities. This study reports on the committee's ability to achieve these goals. Procedure An online survey was sent to YIs who were registered with the program from 2004 to2015, assessing three major domains: (1) overall experience with the mentor pairing, (2) satisfaction with the program, and (3) academic accomplishments of the mentees. Results The response rate was 64% (110/171). Overall, YIs rated the success of their mentorship pairing as 7.2 out of 10 (median) (25th, 75th quartile 3.6, 9.6). The direct effects of the mentorship program included 70% YIs reporting a positive effect on their career, 40% reporting any grant or manuscript resulting from the pairing, 47% forming a new research collaboration, and 43% receiving appointment to a COG committee. Respondents reported success in COG with 38% authoring a manuscript on behalf of COG and 65% reporting a leadership position including seven current or past COG discipline chairs and 20 study chairs. Finally, 74% of respondents said they would consider serving as mentors in the program in the future. Conclusion The COG YI mentorship program has been well received by the majority of the participants and has helped to identify and train many current leaders in COG.
7 citations
••
7 citations
••
TL;DR: Ureteroscopy can be considered first-line therapy for mid- or distal ureteral stones, however, it shares a similar efficacy rate as extracorporeal shock wave lithotripsy for the treatment of renal calculi.
Abstract: Pediatric ureteroscopy has been increasingly used to manage both ureteral and renal stones. Unfortunately, there are no current standardized recommendations when treating pediatric stone disease so the modality chosen is left to the treating surgeon. A review of the current literature on pediatric ureteroscopy was used to compile this article. For the purposes of this review, the majority of series include stones ≤1 cm. Ureteroscopy is considered to be first-line therapy in treating mid- to distal ureteral stones and is rapidly evolving as an acceptable first-line therapy for renal stones as well. Limitations do exist and include stone composition, location, size, as well as the unique anatomic challenges faced by pediatric urologists in terms of anomalous kidneys and/or reconstructed urinary tracts. In conclusion, ureteroscopy can be considered first-line therapy for mid- or distal ureteral stones, however, it shares a similar efficacy rate as extracorporeal shock wave lithotripsy for the treatment of renal calculi. There is a need for direct comparison in the literature of all modalities treating pediatric stone disease to facilitate guidelines that help treating surgeons choose the most efficacious modality offering the highest success rates with the lowest morbidity.
7 citations
••
TL;DR: A better knowledge of drug reactions that can occur in antibiotic allergy and monoclonal allergy can aid a provider in better management of their drug-allergic pediatric patients.
7 citations
Authors
Showing all 1056 results
Name | H-index | Papers | Citations |
---|---|---|---|
Dan M. Roden | 132 | 859 | 67578 |
Kathryn M. Edwards | 102 | 628 | 39467 |
Agnes B. Fogo | 98 | 578 | 38840 |
James E. Crowe | 83 | 430 | 22045 |
Luc Van Kaer | 79 | 261 | 26242 |
John A. Phillips | 69 | 270 | 16980 |
Louis J. Muglia | 68 | 254 | 15777 |
Douglas B. Johnson | 65 | 331 | 18439 |
Keith T. Wilson | 63 | 238 | 13002 |
Michael R. DeBaun | 62 | 369 | 14812 |
Simon W. Hayward | 61 | 191 | 13131 |
Wendy L. Stone | 61 | 150 | 17231 |
Arnold W. Strauss | 60 | 209 | 10792 |
Dominique Delbeke | 59 | 170 | 14652 |
Thomas B. Newman | 58 | 239 | 11638 |